CIK: 0000310158 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value ($000): $164,284 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | MODERNA INC | 2,308,190 | $65,437 | 39.8% | $47.80 | -25.8% | COM | 60770K107 |
| PSNL | PERSONALIS INC | 14,044,943 | $49,298 | 30.0% | $4.62 | +2.9% | COM | 71535D106 |
| KYMR | KYMERA THERAPEUTICS INC | 772,165 | $21,134 | 12.9% | $45.17 | -19.3% | COM | 501575104 |
| — | ENTRADA THERAPEUTICS INC | 1,739,768 | $15,728 | 9.6% | $17.29 | — | COM | 29384C908 |
| ALEC | ALECTOR INC | 3,545,719 | $4,361 | 2.7% | $3.76 | -56.7% | COM | 014442107 |
| — | EVAXION BIOTECH A/S | 1,214,126 | $2,246 | 1.4% | $1.40 | — | SPONSORED ADS | 29970R204 |
| — | SUTRO BIOPHARMA INC | 2,723,509 | $1,772 | 1.1% | $1.84 | — | COM | 869367102 |
| — | LAVA THERAPEUTICS NV | 1,149,345 | $1,460 | 0.9% | $0.95 | — | SHS | N51517105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 93,414 | $1,259 | 0.8% | $21.74 | -21.7% | COM | 92790C104 |
| XLO | XILIO THERAPEUTICS INC | 1,483,758 | $1,075 | 0.7% | $0.98 | -8.6% | COM | 98422T100 |
| CARM | CARISMA THERAPEUTICS INC | 1,473,240 | $457 | 0.3% | $0.82 | -46.2% | COM | 14216R101 |
| NEUP | NEUPHORIA THERAPEUTICS INC | 10,027 | $58 | 0.0% | $3.53 | +32.3% | COM | 64136E102 |